InvestorsHub Logo
Replies to #97467 on Biotech Values
icon url

rkrw

06/19/10 12:17 PM

#97469 RE: genisi #97467

I think I'll chomp on a few carrots while waiting for an answer to that one. :)
icon url

DewDiligence

06/19/10 2:05 PM

#97471 RE: genisi #97467

Caveat emptor re IBPM! The company’s claims remind me of the bankrupt LSBC (#msg-8990370, #msg-9008295). The similarity between the two companies is probably not a coincidence: Robert L. Erwin, president of IBPM, was the founder of LBSC and chief pumper of that company’s failed attempt to make drugs from transgenic plants.
icon url

drbio45

06/19/10 5:26 PM

#97492 RE: genisi #97467

it is more versatile because it can be used for vaccines where you need to react quickly. A trangenic product could not do that.

If they get a bad batch they can throw it out and infiltrate more plants. That wouldn't be as simple for Protalix.

It sounds complicated but the process is actually very simple